Please login to the form below

Not currently logged in
Email:
Password:

chemotherapy

This page shows the latest chemotherapy news and features for those working in and with pharma, biotech and healthcare.

First-line ovarian approval cements AZ’s Lynparza lead

First-line ovarian approval cements AZ’s Lynparza lead

The new FDA approval means that Lynparza (olaparib) can be given to patients who are in complete or partial response to first-line treatment with platinum-based chemotherapy for ovarian, fallopian ... The study showed Lynparza achieved a

Latest news

More from news
Approximately 6 fully matching, plus 755 partially matching documents found.

Latest Intelligence

  • Is China ready for a pharmaceutical gold rush?

    Earlier this year, data showed Keytruda combined with chemotherapy could cut the risk of death among previously untreated lung cancer patients by 51%.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    that has not spread widely around the body after platinum chemotherapy or radiotherapy. ... However, recent overall survival results from the MYSTIC trial, which studied Imfinzi with CTLA4 inhibitor tremelimumab, have just confirmed the combination

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Last year, the FDA approved Merck’s Keytruda (pembrolizumab) as a first-line agent alongside chemotherapy for metastatic NSCLC on data showing the chance of cancer progression was cut in half. ... Opdivo after standard treatment of early-stage lung

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    After all, so many of today’s life-saving healthcare advances, from cancer chemotherapy to heart surgery, rely on effective antibiotics being available to prevent infections in patients.

  • Taking a lean and careful approach Taking a lean and careful approach

    Chemotherapy and Pharmacology, which concluded its treatment regimen showed ‘encouraging clinical benefit’.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics